Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00747240 · ClinicalTrials.gov registry record
Platelet-activating Factor Acetylhydrolase (Paf-ah) Gene Expression
A clinical trial, sponsored by University of Utah.
- Completed
- Registry status
- 139
- Enrollment target
NCT00747240 is a clinical trial that has completed, run by University of Utah. The registered enrollment target is 139 participants.
The verdict
NCT00747240 has completed, sponsored by University of Utah.
- COMPLETED
- Registry status
- 139 participants
- Enrollment target
Study Summary
This is a prospective observational study to determine whether there is an association between the presence of platelet-activating factor acetylhydrolase (PAF-AH) gene polymorphisms and the development of chronic lung disease in very low birth wight infants. Infants \< 1500 grams at birth who require mechanical ventilation will be enrolled in the first 5 days of life after obtaining informed consent. A total of 1 ml of blood will be drawn and utilized for isolation of DNA for genotyping and for measurement of PAF-AH activity in serum.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 139 participants |
| Start Date | 2002-02 |
| Est. Completion | 2014-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00747240
The ClinicalTrials.gov registry entry for NCT00747240 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 139 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Utah, which has 818 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00747240 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00747240 about?
NCT00747240 is a clinical study titled "Platelet-activating Factor Acetylhydrolase (Paf-ah) Gene Expression". This is a prospective observational study to determine whether there is an association between the presence of platelet-activating factor acetylhydrolase (PAF-AH) gene polymorphisms and the development of chronic lung disease in very low birth wight infants. Infants \< 1500 grams at birth who requir...
What is the current status of trial NCT00747240?
This trial is currently completed. The enrollment target is 139 participants. The study started on 2002-02. Estimated completion is 2014-12.
Who is sponsoring clinical trial NCT00747240?
This trial is sponsored by University of Utah, which has 818 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.